Daniel Swisher
President
Other
COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Jazz Pharmaceuticals plc (JAZZ) | Former President and COO | $834,869 | $5,528,973 |
| 2022 | Jazz Pharmaceuticals plc (JAZZ) | Former President and COO | $801,433 | $5,953,745 |
| 2021 | Jazz Pharmaceuticals plc (JAZZ) | Former President and COO | $711,154 | $5,403,892 |
| 2020 | Jazz Pharmaceuticals plc (JAZZ) | President, COO | $713,654 | $4,471,087 |
| 2019 | Jazz Pharmaceuticals plc (JAZZ) | President RenéeGalá | $667,308 | $4,707,407 |
| 2018 | Jazz Pharmaceuticals plc (JAZZ) | President and COO RenéeGalá | $608,173 | $5,753,341 |
Executive changes
Earnings-call appearances
-
Jazz Pharmaceuticals plc Q1 FY2023 Earnings Call2023-05-10
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q4 FY2021 Earnings Call2022-03-01
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q3 FY2021 Earnings Call2021-11-09
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q1 FY2021 Earnings Call2021-04-20
Jazz Pharmaceuticals plc (JAZZ)